Jocelyn Carino rescued a cat from underneath a car in Orlando one cold day in November. Two months later, she was intubated ...

A case demonstrating sustained remission of exercise-induced asthma, allergic oropharyngeal symptoms, and recurrent ...

Estimated annual cost of asthma management totaled $2,181 per SMART-prescribed patient compared with $2,235 with traditional ...

(THE CONVERSATION) Researchers and doctors are beginning to modernize asthma treatment using innovative therapies. Asthma is a common, chronic and treatable lung disease that touches nearly every ...

Irvine-based upstart Spiro Medical, whose chairman is Axonics founder Raymond Cohen, raised a $67 million Series A funding ...

Spiro Medical, which debuted last year, reeled in $67 million in series A funding it plans to use to develop its novel treatment for asthma. Dubbed the Pulmonary Neuromodulation System, the platform ...

Exdensur is the first and only ultra-long-acting biologic with twice-yearly dosing approved for patients with severe asthma with an eosinophilic phenotype Approval based on SWIFT trials showing ...

A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...

What Is Exdensur, and Why Does It Matter? Exdensur (depemokimab) is a new type of ultra long-acting biologic medicine approved by the FDA as an add-on maintenance treatment for severe eosinophilic ...

Asthma care continues to develop, particularly in how treatment and long-term management are approached. This article outlines current treatment and management recommendations for patients aged 12 and ...

Monthly injection with tezepelumab helped 90% of patients with severe asthma reduce intake of daily steroid tablets. The corresponding study was published in The Lancet Respiratory Medicine. “In this ...